Hu-Mik-Beta-1 / National Institute of Neurological Disorders and Stroke  >>  Phase 1
Welcome,         Profile    Billing    Logout  

3 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Hu-Mik-Beta-1 / National Institute of Neurological Disorders and Stroke
NCT00076180: Hu-Mik-beta1 to Treat T-Cell Large Granular Lymphocytic Leukemia

Completed
1
9
US
Hu-MiK-Beta-1
National Cancer Institute (NCI)
T-Cell Large Granular Lymphocytic Leukemia, Leukemia, T-Cell Large Granular Lymphocytic
11/10
01/19
NCT00076843: Hu Mik-Beta-1 to Treat HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis

Completed
1
9
US
Hu MiK-Beta-1
National Institute of Neurological Disorders and Stroke (NINDS)
HTLV-1
10/17
06/19
NCT01893775: Antibody Treatment for Advanced Celiac Disease

Completed
1
5
US
Hu-Mik- Beta-1
National Cancer Institute (NCI), Mayo Clinic
Celiac Disease, Celiac Sprue, Gluten Enteropathy, Gluten-Sensitive Enteropathy
12/19
12/19

Download Options